Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorJanssen, Harry L A
dc.contributor.authorHou, Jinlin
dc.contributor.authorAsselah, Tarik
dc.contributor.authorChan, Henry Lik Yuen
dc.contributor.authorZoulim, Fabien
dc.contributor.authorTanaka, Yasuhito
dc.contributor.authorButi Ferret, Maria
dc.date.accessioned2023-06-14T09:41:00Z
dc.date.available2023-06-14T09:41:00Z
dc.date.issued2023-07
dc.identifier.citationJanssen HLA, Hou J, Asselah T, Chan HLY, Zoulim F, Tanaka Y, et al. Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection. Gut. 2023 Jul;72(7):1385–98.
dc.identifier.issn1468-3288
dc.identifier.urihttps://hdl.handle.net/11351/9744
dc.descriptionHepatitis crònica; Hepatitis B
dc.description.sponsorshipThis study was sponsored by Janssen (award/grant number: not applicable).
dc.language.isoeng
dc.publisherBMJ
dc.relation.ispartofseriesGut;72(7)
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourceScientia
dc.subjectHepatitis B - Tractament
dc.subjectMedicaments antivírics - Ús terapèutic
dc.subject.meshHepatitis B, Chronic
dc.subject.mesh/drug therapy
dc.subject.meshAntiviral Agents
dc.subject.mesh/therapeutic use
dc.titleRandomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1136/gutjnl-2022-328041
dc.subject.decshepatitis B crónica
dc.subject.decs/farmacoterapia
dc.subject.decsantivíricos
dc.subject.decs/uso terapéutico
dc.relation.publishversionhttp://dx.doi.org/10.1136/gutjnl-2022-328041
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Janssen HLA] Toronto General Hospital, Toronto, Ontario, Canada. Erasmus Medical Center, Rotterdam, Zuid-Holland, The Netherlands. [Hou J] Nanfang Hospital, Southern Medical University, Guangzhou, China. [Asselah T] Université de Paris Cité, INSERM UMR1149, Hôpital Beaujon AP-HP, Clichy, France. [Chan HLY] The Chinese University of Hong Kong, Hong Kong SAR, China. [Zoulim F] Hospices Civils de Lyon and Lyon University & INSERM U1052-Cancer Research Institute of Lyon, Lyon, France. [Tanaka Y] Department of Gastroenterology and Hepatology, Kumamoto University, Kumamoto, Japan. [Buti M] Vall d’Hebron Hospital Universitari, Barcelona, Spain. CIBERHED del Instituto Carlos III, Barcelona, Spain
dc.identifier.pmid36697207
dc.identifier.wos000921642100001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail
Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple